Skip to main content

Month: February 2021

Dividend 15 Split Corp. II Regular Monthly Dividend Declaration for Preferred Share

TORONTO, Feb. 18, 2021 (GLOBE NEWSWIRE) — Dividend 15 Split Corp. II (“Dividend 15 II”) declares its regular monthly distribution of $0.04792 for each Preferred share. Distributions are payable March 10, 2021 to shareholders on record as at February 26, 2021.There will not be a distribution paid to the Class A Shares for February 26, 2021 as per the Prospectus which states no regular monthly dividends will be paid on the Class A shares in any month as long as the net asset value per unit is equal to or less than $15.00.Since inception Class A shareholders have received a total of $13.30 per share and Preferred shareholders have received a total of $7.56 per share inclusive of this distribution, for a combined total of $20.86.Dividend 15 II invests in a high quality portfolio of leading Canadian dividend-yielding stocks...

Continue reading

“Willy’s Wonderland” Delivers in its World Premiere at Home as a PVOD Release

NEW YORK, Feb. 18, 2021 (GLOBE NEWSWIRE) — Screen Media Ventures, a Chicken Soup for the Soul Entertainment, Inc. (Nasdaq: CSSE) company, announced today the successful opening weekend Premium Video-On-Demand (“PVOD”) release of horror thriller Willy’s Wonderland, starring Nicolas Cage.The feature by Landmark Studio Group (“Landmark”) is directed by Kevin Lewis from a screenplay written by G.O. Parsons. In Willy’s Wonderland, a quiet loner (Cage) finds himself stranded in a remote town when his car breaks down. Unable to pay for the repairs he needs, he agrees to spend the night cleaning Willy’s Wonderland, an abandoned family fun center. But this wonderland has a dark secret that the “The Janitor” is about to discover. He soon finds himself trapped inside Willy’s and locked in an epic battle with the possessed animatronic...

Continue reading

ThreeD Capital Completes $375,000 Investment Into Intellabridge Technology Corporation

TORONTO, Feb. 18, 2021 (GLOBE NEWSWIRE) — ThreeD Capital Inc. (“ThreeD” or the “Company”) (CSE:IDK) (OTCQB:IDKFF), a Canadian-based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive technologies sectors, is pleased to announce a $375,000 investment in Intellabridge Technology Corporation (“Intellabridge”) (CSE: INTL) (OTC Pink: CRBTF) (FSE: 98AA) a blockchain technology company focused on developing decentralized finance technology solutions.The Company has acquired 2,500,000 units (the “Units”) at a price of $0.15 per Unit for aggregate proceeds of $375,000. Each Unit consists of one (1) common share of Intellabridge (a “Common Share”) and one Common Share purchase warrant (a “Warrant”), exercisable at a price of $0.45 per Warrant. The Warrants will expire two (2) years...

Continue reading

Recruiter.com Launches Subscription Service for Curated Talent

New Video-Based Talent Solution Helps Improve ROI on $200B of Annual Hiring SpendHOUSTON, Feb. 18, 2021 (GLOBE NEWSWIRE) — Recruiter.com Group, Inc. (OTCQB: RCRT), an AI-enabled and Video hiring platform with the world’s largest network of on-demand recruiters, today announced the launch of its new-to-market product, Scouted by Recruiter.com, a highly specialized candidate curation tool that leverages the power of AI and talent experts to help hiring managers recruit top talent, faster.To learn more about the new subscription offering, please visit: https://start.recruiter.com/scouted“Companies spend over $4,000 for each hire they make; Recruiter.com can help both reduce this up-front cost and deliver an increased return on investment,” said Evan Sohn, CEO of Recruiter.com. “Our Scouted product reduces the time-to-hire with...

Continue reading

Ársreikningur REG 1 vegna ársins 2020

REG 1 sjóður sem er í rekstri Stefnis hf. gaf út skuldabréf tekin til viðskipta hjá NASDAQ OMX Iceland hf. árið 2013.Hagnaður 247 þús. króna varð á rekstri sjóðsins á árinu samkvæmt rekstrarreikningi.Hrein eign sjóðsins nam 1.892 þús. króna samkvæmt efnahagsreikningi.Ársreikningurinn var endurskoðaður af Deloitte ehf. í samræmi við alþjóðlega endurskoðunarstaðla. Það er álit endurskoðanda að ársreikningurinn gefi glögga mynd af afkomu sjóðsins á árinu 2020, efnahagi hans 31. desember 2020 og breytingu á hreinni eign sjóðsins á árinu 2020, í samræmi við lög um ársreikninga.Hægt verður að nálgast ársreikning sjóðsins frá og með deginum í dag á heimasíðu Stefnis hf. www.stefnir.isNánari upplýsingar um ársreikning fagfjárfestasjóðsins REG 1 veitir Jóhann Möller, framkvæmdastjóri Stefnis, í síma 444 7471.Viðhengi2020 – Ársreikningur...

Continue reading

Ársreikningur KLS vegna ársins 2020

KLS sjóður sem er í rekstri Stefnis hf. gaf út skuldabréf tekin til viðskipta hjá NASDAQ OMX Iceland hf. árið 2013.Hagnaður 236 þús. krónur varð á rekstri sjóðsins á árinu samkvæmt rekstrarreikningi.Hrein eign sjóðsins nam 1.802 þús. króna samkvæmt efnahagsreikningi.Ársreikningurinn var endurskoðaður af Deloitte ehf. í samræmi við alþjóðlega endurskoðunarstaðla. Það er álit endurskoðanda að ársreikningurinn gefi glögga mynd af afkomu sjóðsins á árinu 2020, efnahagi hans 31. desember 2020 og breytingu á hreinni eign sjóðsins á árinu 2020, í samræmi við lög um ársreikninga.Hægt verður að nálgast ársreikning sjóðsins frá og með deginum í dag á heimasíðu Stefnis hf. www.stefnir.isNánari upplýsingar um ársreikning fagfjárfestasjóðsins KLS veitir Jóhann Möller, framkvæmdastjóri Stefnis, í síma 444 7471.Viðhengi2020 – Ársreikningur KLS...

Continue reading

WPD and CNS Pharmaceuticals Announce Positive Opinion of the Polish Central Ethics Committee for the WPD-201 Study and Central IRB Study Level Approval for the CNS-201 Study

WPD Pharmaceuticals plans to initiate a Berubicin Phase 2 adult GBM trial in the first half of 2021 and a multicenter pediatric malignant glioma Phase 1 clinical trial in 2021CNS Pharmaceuticals plans to initiate a Berubicin adult GBM trial in Q1 2021HOUSTON, Feb. 18, 2021 (GLOBE NEWSWIRE) — WPD Pharmaceuticals (CSE:WBIO) (8SV1.F) (“WPD”) and CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) (“CNS” or the “Company”), biopharmaceutical companies specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today announced that WPD Pharmaceuticals received a positive opinion of the Lower Silesian Medical Chamber Ethics Committee in Wrocław, Poland for its planned upcoming Berubicin clinical trial in adults with Glioblastoma Multiforme (GBM)...

Continue reading

Dakota Territory Resource Corp Announces Extension of Purchase Right

Lead, South Dakota, Feb. 18, 2021 (GLOBE NEWSWIRE) — Dakota Territory Resource Corp (OTCQB: DTRC) (“Dakota Territory” or the “Company”) announced today that on February 15, 2021 the Company and JR Resources Corp. (“JR”) mutually agreed to extend for 30 days the option for JR to purchase up to an additional 72,900,000 shares of common stock for up to an additional $10,935,000.“We are very pleased with the progress we have made with JR Resources.” said President and CEO of Dakota Territory, Jerry Aberle. “Travel restrictions and our concern for the health of our teams have had an impact on our collective efforts to close as planned.  We are very much engaged and working to wrap things up quickly, and to the benefit of Dakota Territory and our shareholders.”About JR Resources Corp.JR Resources Corp. is a well-funded...

Continue reading

Dividend Select 15 Corp. Declares Monthly Dividend

TORONTO, Feb. 18, 2021 (GLOBE NEWSWIRE) — Dividend Select 15 Corp. (The “Company”) declares its monthly distribution of $0.05542 per Equity share. The distribution is payable March 10, 2021 to shareholders on record as of February 26, 2021.Under the distribution policy announced in September 2014, the monthly dividend payable on the Equity shares is determined by applying a 10.00% annualized rate on the volume weighted average market price (VWAP) of the Equity shares over the last 3 trading days of the preceding month. As a result, Equity shareholders of record on February 26, 2021 will receive a dividend of $0.05542 per share based on the VWAP of $6.65 payable on March 10, 2021. The yield will remain stable at 10.00% (based on the VWAP) under this distribution policy.Since inception, Equity shareholders have received...

Continue reading

The Grand Hotel Savoia, A Radisson Collection Hotel and Radisson Residences Savoia Palace open their doors in the heart of the Dolomites

The historic Grand Hotel Savoia Cortina d’Ampezzo, A Radisson Collection Hotel, and the Radisson Residences Savoia Palace are proud to open their doors following an extensive renovation, while still maintaining both properties’ unique alpine identities. Cortina d’Ampezzo is one of the world’s leading year-round resort destinations offering; world-class skiing and snowboarding in the winter and hiking, biking, and rock climbing in the summer.Built in 1912, the Grand Hotel Savoia Cortina d’Ampezzo remains true to its original Art Nouveau style as a symbol of Italian elegance and contemporary style. The 5-star hotel recently joined Radisson Hotel Group and is operated by Zeus International. Strategically located in the centre of Cortina, the hotel features 126 guest rooms, including 19 junior suites and 8 suites, a lobby and cigar...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.